360Dx

What 360Dx does

360Dx is a B2B subscription-based clinical diagnostics technology and disease research news publication operating as a business unit of Crain Communications Inc., a private U.S. media conglomerate, under the GenomeWeb publishing umbrella. It serves clinical laboratory professionals, diagnostics manufacturers, healthcare providers and researchers, and laboratory industry policymakers with consolidated coverage of FDA approvals, regulatory changes, reimbursement developments, clinical trial results, and business strategy shifts across the fragmented diagnostics landscape.

The platform's core product is a digital publishing and subscription-gated content site (360dx.com) with supporting tools including an FDA 510(k) IVD Tests and Instruments Tracker, Coronavirus Test Tracker, webinars, white papers, and job listings. The underlying technology stack is a standard digital publishing platform with RSS feeds, email newsletters, premium content access controls, and multi-channel distribution across Twitter (360DxNews) and LinkedIn (GenomeWeb LLC). Coverage spans diagnostics modalities (molecular diagnostics, immunoassays, tissue-based testing, clinical chemistry, hematology/coagulation, point-of-care testing, companion diagnostics) and disease areas (cancer, infectious disease, cardiovascular, neurological, autoimmune, inherited, reproductive, respiratory, GI, COVID-19).

360Dx monetizes through two streams: recurring premium subscriptions with annual quote-based pricing (pricing is not publicly disclosed) and advertising/sponsored content including partner content sections and webinar sponsorships. The go-to-market is primarily content marketing and direct subscription sales targeting enterprise buyers, with sister-publication cross-promotion through GenomeWeb, Precision Medicine Online, and PMLS Events under the Crain Communications portfolio. The platform operates globally, with no disclosed AI/ML capabilities, no funding rounds, and no M&A activity in the input data.

Name

360Dx

Legal name

Crain Communications Inc.

Website

https://360dx.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

360Dx is a B2B subscription-based clinical diagnostics and disease research news publication serving laboratory professionals, diagnostics manufacturers, healthcare providers, and policymakers with premium news, regulatory tracking, and industry intelligence tools.

Ownership category

akta.pro rank

Headquarters

HQ city

Fulton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Subscription Revenue: The platform offers premium subscriptions for access to restricted content, with options for annual quotes and trial periods. Users can subscribe to access premium articles and restricted content areas.
2. Advertising and Sponsorships: The platform generates revenue through sponsored content, advertisements, and partner content sections. The website features sponsorship sections and partner content areas.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

360Dx is a B2B subscription-supported clinical diagnostics news and analysis website that publishes breaking news, regulatory updates, reimbursement intelligence, and disease research coverage for the in vitro diagnostics industry. It serves clinical lab professionals, diagnostics manufacturers, healthcare providers, and policy analysts with both free and premium gated content, supplemented by specialized tools such as an FDA 510(k) IVD clearance tracker and a Coronavirus Test Tracker.

Product overview

360Dx is a clinical diagnostics technology and disease research news website that provides news and analysis on various diagnostic categories including Molecular Diagnostics, Immunoassays, Tissue-Based Testing, Clinical Chemistry, Hematology/Coagulation, Point-of-Care Testing, and Companion Diagnostics. The site covers disease areas such as Cancer, Infectious Disease, Cardiovascular Disease, and others. It also provides resources including webinars, white papers, job listings, FDA 510(k) tracker, and Coronavirus test tracker. The platform functions as a news and information service rather than a commercial product.

Differentiator

Problem solved

Functional benefit

Brands

• GenomeWeb: Parent brand/company that operates 360Dx as a business unit
• Precision Medicine Online
• PMLS Events

Products and services

• 360Dx News Platform A B2B subscription-supported clinical diagnostics news and analysis website providing news, regulatory updates, FDA approval tracking, reimbursement intelligence, and disease research coverage for clinical laboratory professionals, diagnostics manufacturers, healthcare providers, and policy analysts.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• GenomeWebcoreOthers360Dx operates as a sister publication under the GenomeWeb umbrella, part of Crain Communications. GenomeWeb is a leading source for molecular diagnostics and life sciences news, providing editorial synergy and cross-promotion between publications.
• Precision Medicine OnlinecoreOthers360Dx is partnered with Precision Medicine Online as a sister publication under the GenomeWeb/Crain Communications network, covering precision medicine topics that intersect with diagnostic developments.
• PMLS EventsminorOthers360Dx is connected to PMLS Events (Precision Medicine Leaders' Summit) as part of the GenomeWeb event and publishing ecosystem, providing cross-promotional opportunities for industry events.
• Crain CommunicationscoreOthers360Dx is a business unit of Crain Communications Inc., a major publishing company providing corporate infrastructure, sales support, and brand authority. Crain Communications owns multiple industry-specific publications and events.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• MedTech Dive: Industry Dive/Informa B2B news publication covering medical devices and diagnostics. Directly comparable in editorial scope (FDA clearances, coverage decisions, industry deals) and B2B subscription + advertising model.
• BioSpace: Life sciences B2B news, job board, and industry intelligence platform. Overlaps with 360Dx in serving diagnostics and biotech employers seeking both advertising and recruitment reach.
• Endpoints News: Subscription-driven B2B news outlet focused on biopharma R&D, dealmaking, and regulatory developments. Comparable in its paywalled news + sponsored-content monetization aimed at industry executives.
• Diagnostics World (HMP): Diagnostics-focused trade publication from HMP covering IVDs, molecular diagnostics, and regulatory developments. Directly comparable niche competitor to 360Dx in diagnostics industry coverage and B2B sponsorship.
• BioCentury: Subscription-based B2B biopharma intelligence service with a similar paywall + sponsored-content model. Comparable in serving biopharma executives with curated regulatory, financing, and deal intelligence.
• Clinical Lab Products (HMP): Trade publication covering clinical laboratory operations, instrumentation, and diagnostics — same clinical-lab-manager audience as 360Dx with overlapping editorial scope and B2B advertising model.
• GenomeWeb: Sister publication under the same GenomeWeb/Crain Communications umbrella covering molecular diagnostics and life sciences research news. Direct overlap in audience (clinical lab professionals, diagnostics manufacturers) and editorial coverage with 360Dx.
• Dark Daily / Dark Intelligence Group: B2B intelligence service focused specifically on the clinical laboratory industry — the most directly comparable niche peer to 360Dx in terms of audience (clinical lab managers, pathologists, diagnostics executives).

Broad incumbents

• STAT News: Boston Globe Media-owned B2B-and-consumer health/life sciences news outlet covering drug development, diagnostics, and policy. Competes for diagnostics-industry readership at the executive level with substantially broader audience scale.
• Fierce Biotech / Fierce Pharma: Established B2B trade media brand (Questex) covering biotech and pharma news with significant diagnostics adjacency. Operates a similar subscription + advertising + events model but across a broader life-sciences vertical.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/360dxnews
• LinkedInlinkedin.com/company/360dx
• Facebookfacebook.com/360diagnostics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 360Dx